NOVARTIS AG - Ordinary Shares (NVS)

CUSIP: 66987V109

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Ordinary Shares
Shares outstanding
2,181,288,547
Total 13F shares
133,423,708
Share change
-4,323,807
Total reported value
$16,144,171,651
Put/Call ratio
100%
Price per share
$121.01
Number of holders
1,369
Value change
-$490,795,407
Number of buys
589
Number of sells
549

Quarterly Holders Quick Answers

What is CUSIP 66987V109?
CUSIP 66987V109 identifies NVS - NOVARTIS AG - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q2 2025

As of 30 Jun 2025, NOVARTIS AG - Ordinary Shares (NVS) was held by 1,369 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 133,423,708 shares. The largest 10 holders included Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, DIMENSIONAL FUND ADVISORS LP, MORGAN STANLEY, Fisher Asset Management, LLC, LOOMIS SAYLES & CO L P, BANK OF AMERICA CORP /DE/, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 1,374 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.